Summary

The global Biomanufacturing in Platform Molecule market size is predicted to grow from US$ 84948 million in 2025 to US$ 135898 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.
A platform molecule is a bio-based (or biologically derived) compound whose constituent elements originate entirely from biomass (biologically derived matter, excluding fossil carbon sources) and which serves as a building block for the production of other chemicals. These molecules are typically small in size, relatively simple in structure, and of lower value; ideally, they are produced in high yields (or at least possess the potential for large-scale production) and are regarded as bio-based alternatives to fossil-based chemicals. In the traditional sense, bio-based platform molecules refer to compounds obtained from biomass through methods such as chemical synthesis, biological conversion, or extraction; within the context of biomanufacturing, however, platform molecules specifically denote products prepared via biological fermentation or enzymatic processes.
The global "Dual Carbon" agenda has emerged as one of the most significant macro-level drivers for the biomanufacturing sector. Governments worldwide are increasingly integrating bio-based materials into their carbon neutrality roadmaps, creating market opportunities through a combination of subsidies and regulatory mandates. For instance, the EU Green Deal and various national carbon pricing mechanisms have raised the cost of high-carbon petrochemical products, thereby indirectly enhancing the competitiveness of bio-based alternatives. Furthermore, plastic restriction mandates and renewable energy quotas in many nations have directly established minimum demand thresholds for bio-based products—such as mandatory blending ratios for bioethanol. This is particularly evident in hard-to-abate sectors like aviation and shipping, where nations are pinning their hopes on biofuels, thereby stimulating investment in related platform molecules (e.g., the production of Sustainable Aviation Fuel, or SAF, from ethanol). Additionally, strategic initiatives such as the bioeconomy blueprints and three-year action plans promulgated by nations like China are driving the sector forward from an industrial policy perspective, sending clear signals to enterprises to proactively position themselves for future growth. It is foreseeable that future policies will shift from merely encouraging volume to guiding quality—for instance, by establishing certification standards for bio-based content and carbon footprint accounting, or by incorporating bio-based materials into government procurement "green lists." This will render policy-driven incentives more institutionalized and enduring, insulating the industry's development from the volatility of political transitions and fostering a stable external environment.
An increasing number of multinational brands are announcing commitments to sustainable sourcing, thereby effectively creating a pool of "certain" demand for bio-based materials. For example, automotive giants like BMW and Mercedes-Benz have pledged to significantly increase the proportion of renewable materials used in their vehicles by 2030, while beverage behemoths Coca-Cola and PepsiCo are aiming to transition to packaging made entirely from 100% bio-based plastics. In the fashion and retail sectors, brands such as Adidas and Nike have launched footwear and apparel lines incorporating bio-based raw materials, thereby emphasizing their eco-friendly credentials. The procurement specifications articulated by these brands are explicit and precise: they clearly define the required performance attributes, the necessary quantities, and the delivery timelines. This provides clear market guidance for upstream enterprises, incentivizing them to develop materials that specifically address these brands' requirements. It can be argued that these low-carbon procurement pledges from the brand side have become a direct catalyst for investment within the industry. Furthermore, the younger generation of consumers is becoming increasingly attuned to the environmental attributes of the products they purchase; marketing themes such as "plant-based" and "petroleum-free" now carry significant market appeal. This trend is prompting a growing number of companies in the consumer electronics and home goods sectors to experiment with bio-based components as a means of enhancing their brand image. While this form of consumer-driven demand is currently most pronounced in developed markets, it demonstrates a clear trend toward global diffusion. As consumer education becomes more widespread and the willingness to accept "green premiums" increases, even larger end-markets will open up for bio-based products. Enterprises are also increasing their investment in marketing and promotion to further emphasize their "green" selling points, thereby creating a positive feedback loop that drives demand.
Beyond policy mandates and market-driven initiatives, an even more compelling and rigid driving force stems from mounting climate and environmental pressures. The rising frequency of extreme weather events and severe marine plastic pollution are compelling governments and the public alike to seek viable solutions. Bio-based chemicals are uniquely positioned to address both carbon emission reduction and plastic pollution control; compared to their petrochemical counterparts, they typically boast a carbon footprint that is at least 50% lower, and many are biodegradable. Consequently, whether through global climate accords or regional environmental mandates, the bio-manufacturing industry has been provided with a prominent stage upon which to operate. For instance, the UN-championed "Net Zero by 2050" goal effectively mandates that nearly every industry incorporate carbon-negative or carbon-neutral feedstocks; given the inherent difficulties in decarbonizing traditional chemical manufacturing, bio-based pathways have emerged as a compelling alternative. Similarly, within the Nationally Determined Contributions (NDCs) submitted in the wake of the Paris Agreement, numerous countries have explicitly identified the development of biomaterials and bioenergy as key strategies for achieving their emission reduction targets. On the environmental front, the remediation of plastic waste and toxic chemicals remains a long-term imperative, ensuring that the demand for alternative materials will not abate. In essence, as long as the trends of climate change and environmental degradation persist—rather than being reversed—the impetus for bio-based chemicals will endure, and indeed, may intensify further as the urgency of the situation grows. While this pressure constitutes a "passive" driver, it is nonetheless robust, globally pervasive, and destined to grow ever stronger.
The industry's internal momentum is fueled by advancements in science and technology. New technologies—such as synthetic biology, gene editing, and automated fermentation—are continuously boosting production efficiency, transforming previously unfeasible processes into tangible realities. For example, the targeted modification of microbial strains using CRISPR technology has drastically shortened breeding cycles; AI algorithms are facilitating the design of high-yield metabolic pathways; and the adoption of continuous fermentation and novel separation techniques is driving down energy consumption per unit of output. Historically, many "platform chemicals" remained confined to the conceptual stage or small-scale laboratory trials; however, in recent years, technological breakthroughs have paved the way for their industrial-scale commercialization. A case in point is 3-hydroxypropionic acid (3-HP), which previously suffered from low yields and prohibitive costs, but whose commercial viability is now being significantly enhanced through the development of novel microbial strains by companies such as LG Chem. Each technological breakthrough translates directly into reduced production costs, thereby enhancing the market competitiveness of bio-based products. This is particularly evident in the diversification of feedstocks, where advancements in biorefinery technologies have enabled the utilization of non-food resources—such as lignocellulosic biomass and waste gases—thereby reducing long-term reliance on volatile food crop prices. Furthermore, as production volumes scale up, parallel advancements in technologies for recycling and utilizing by-products are contributing to improved profit margins across the industry. Historical precedent indicates that the cost of fuel ethanol declined by nearly 40% over a 20-year period, while the price of polylactic acid (PLA) also dropped significantly through economies of scale. Consequently, the "learning curve" effect—driven by advancements in technology and scale—will continue to serve as a key driver for the industry. It is anticipated that, over the next 5 to 10 years, the cost gap between bulk bio-based products and their petrochemical counterparts will gradually narrow—and may even reverse (particularly when factoring in carbon pricing). At that juncture, market choices will be driven more by performance and sustainability than by price. Once this inflection point is reached, it will trigger an explosive surge in demand, which will, in turn, stimulate further investment in technology, thereby creating a virtuous cycle of prosperity.
LPI (LP Information)' newest research report, the “Biomanufacturing in Platform Molecule Industry Forecast” looks at past sales and reviews total world Biomanufacturing in Platform Molecule sales in 2025, providing a comprehensive analysis by region and market sector of projected Biomanufacturing in Platform Molecule sales for 2026 through 2032. With Biomanufacturing in Platform Molecule sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biomanufacturing in Platform Molecule industry.
This Insight Report provides a comprehensive analysis of the global Biomanufacturing in Platform Molecule landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biomanufacturing in Platform Molecule portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biomanufacturing in Platform Molecule market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biomanufacturing in Platform Molecule and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biomanufacturing in Platform Molecule.
This report presents a comprehensive overview, market shares, and growth opportunities of Biomanufacturing in Platform Molecule market by product type, application, key players and key regions and countries.
Segmentation by Type:
C2 Platform Molecule
C3 Platform Molecule
C4 Platform Molecule
C5 Platform Molecule
C6 Platform Molecule
Others
Segmentation by Technology:
Bio-fermentation
Enzymatic Reaction
Segmentation by Application:
Energy
Agriculture
Food and Beverages
Consumer Goods and Daily Chemicals
Pharmaceuticals
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
POET, LLC
Meihua Group
Fufeng Group
CJ Bio
Eppen Biotech
Ajinomoto
ADM
Gevo Inc
Valero
COFCO TEC
Evonik
Ensign Industry
Cargill
Cathay Biotech
Corbion
China BBCA Group
Jungbunzlauer
RZBC Group
Primient Covation LLC
Anhui Huaheng Biotechnology
TTCA Co
Henan Jindan Lactic Acid Technology
Versalis S.p.A
Jiangsu Guoxin Union Energy
Citrique Belge
Shandong Kaison Biochemical
BioUrja Group
Laiwu Taihe Biochemistry
Roquette Frères
Galactic
Henan Xinghan Biotechnology
Shandong Landian Biological
Godavari Biorefineries
Guangdong Tsingda Smart Biotech
Zhejiang Guoguang Biochemistry
Musashino Chemical
Qingdao Langyatai Group
NATURAL Biological Group
Toray
Anhui Xingzhou Pharmaceutical
Goodlactic
Gadot Biochemical Industries
HSF Biotech
Qore, LLC
LG Chemical

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biomanufacturing in Platform Molecule Market Size (2021-2032)
2.1.2 Biomanufacturing in Platform Molecule Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biomanufacturing in Platform Molecule by Country/Region (2021, 2025 & 2032)
2.2 Biomanufacturing in Platform Molecule Segment by Type
2.2.1 C2 Platform Molecule
2.2.2 C3 Platform Molecule
2.2.3 C4 Platform Molecule
2.2.4 C5 Platform Molecule
2.2.5 C6 Platform Molecule
2.2.6 Others
2.2.7 Biomanufacturing in Platform Molecule Market Size by Type
2.2.7.1 Biomanufacturing in Platform Molecule Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.7.2 Global Biomanufacturing in Platform Molecule Market Size Market Share by Type (2021-2026)
2.3 Biomanufacturing in Platform Molecule Segment by Technology
2.3.1 Bio-fermentation
2.3.2 Enzymatic Reaction
2.3.3 Biomanufacturing in Platform Molecule Market Size by Technology
2.3.3.1 Biomanufacturing in Platform Molecule Market Size CAGR by Technology (2021 VS 2025 VS 2032)
2.3.3.2 Global Biomanufacturing in Platform Molecule Market Size Market Share by Technology (2021-2026)
2.4 Biomanufacturing in Platform Molecule Segment by Application
2.4.1 Energy
2.4.2 Agriculture
2.4.3 Food and Beverages
2.4.4 Consumer Goods and Daily Chemicals
2.4.5 Pharmaceuticals
2.4.6 Others
2.4.7 Biomanufacturing in Platform Molecule Market Size by Application
2.4.7.1 Biomanufacturing in Platform Molecule Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.4.7.2 Global Biomanufacturing in Platform Molecule Market Size Market Share by Application (2021-2026)
3 Biomanufacturing in Platform Molecule Market Size by Player
3.1 Biomanufacturing in Platform Molecule Market Size Market Share by Player
3.1.1 Global Biomanufacturing in Platform Molecule Revenue by Player (2021-2026)
3.1.2 Global Biomanufacturing in Platform Molecule Revenue Market Share by Player (2021-2026)
3.2 Global Biomanufacturing in Platform Molecule Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biomanufacturing in Platform Molecule by Region
4.1 Biomanufacturing in Platform Molecule Market Size by Region (2021-2026)
4.2 Global Biomanufacturing in Platform Molecule Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biomanufacturing in Platform Molecule Market Size Growth (2021-2026)
4.4 APAC Biomanufacturing in Platform Molecule Market Size Growth (2021-2026)
4.5 Europe Biomanufacturing in Platform Molecule Market Size Growth (2021-2026)
4.6 Middle East & Africa Biomanufacturing in Platform Molecule Market Size Growth (2021-2026)
5 Americas
5.1 Americas Biomanufacturing in Platform Molecule Market Size by Country (2021-2026)
5.2 Americas Biomanufacturing in Platform Molecule Market Size by Type (2021-2026)
5.3 Americas Biomanufacturing in Platform Molecule Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biomanufacturing in Platform Molecule Market Size by Region (2021-2026)
6.2 APAC Biomanufacturing in Platform Molecule Market Size by Type (2021-2026)
6.3 APAC Biomanufacturing in Platform Molecule Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biomanufacturing in Platform Molecule Market Size by Country (2021-2026)
7.2 Europe Biomanufacturing in Platform Molecule Market Size by Type (2021-2026)
7.3 Europe Biomanufacturing in Platform Molecule Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biomanufacturing in Platform Molecule by Region (2021-2026)
8.2 Middle East & Africa Biomanufacturing in Platform Molecule Market Size by Type (2021-2026)
8.3 Middle East & Africa Biomanufacturing in Platform Molecule Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biomanufacturing in Platform Molecule Market Forecast
10.1 Global Biomanufacturing in Platform Molecule Forecast by Region (2027-2032)
10.1.1 Global Biomanufacturing in Platform Molecule Forecast by Region (2027-2032)
10.1.2 Americas Biomanufacturing in Platform Molecule Forecast
10.1.3 APAC Biomanufacturing in Platform Molecule Forecast
10.1.4 Europe Biomanufacturing in Platform Molecule Forecast
10.1.5 Middle East & Africa Biomanufacturing in Platform Molecule Forecast
10.2 Americas Biomanufacturing in Platform Molecule Forecast by Country (2027-2032)
10.2.1 United States Market Biomanufacturing in Platform Molecule Forecast
10.2.2 Canada Market Biomanufacturing in Platform Molecule Forecast
10.2.3 Mexico Market Biomanufacturing in Platform Molecule Forecast
10.2.4 Brazil Market Biomanufacturing in Platform Molecule Forecast
10.3 APAC Biomanufacturing in Platform Molecule Forecast by Region (2027-2032)
10.3.1 China Biomanufacturing in Platform Molecule Market Forecast
10.3.2 Japan Market Biomanufacturing in Platform Molecule Forecast
10.3.3 Korea Market Biomanufacturing in Platform Molecule Forecast
10.3.4 Southeast Asia Market Biomanufacturing in Platform Molecule Forecast
10.3.5 India Market Biomanufacturing in Platform Molecule Forecast
10.3.6 Australia Market Biomanufacturing in Platform Molecule Forecast
10.4 Europe Biomanufacturing in Platform Molecule Forecast by Country (2027-2032)
10.4.1 Germany Market Biomanufacturing in Platform Molecule Forecast
10.4.2 France Market Biomanufacturing in Platform Molecule Forecast
10.4.3 UK Market Biomanufacturing in Platform Molecule Forecast
10.4.4 Italy Market Biomanufacturing in Platform Molecule Forecast
10.4.5 Russia Market Biomanufacturing in Platform Molecule Forecast
10.5 Middle East & Africa Biomanufacturing in Platform Molecule Forecast by Region (2027-2032)
10.5.1 Egypt Market Biomanufacturing in Platform Molecule Forecast
10.5.2 South Africa Market Biomanufacturing in Platform Molecule Forecast
10.5.3 Israel Market Biomanufacturing in Platform Molecule Forecast
10.5.4 Turkey Market Biomanufacturing in Platform Molecule Forecast
10.6 Global Biomanufacturing in Platform Molecule Forecast by Type (2027-2032)
10.7 Global Biomanufacturing in Platform Molecule Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biomanufacturing in Platform Molecule Forecast
11 Key Players Analysis
11.1 POET, LLC
11.1.1 POET, LLC Company Information
11.1.2 POET, LLC Biomanufacturing in Platform Molecule Product Offered
11.1.3 POET, LLC Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 POET, LLC Main Business Overview
11.1.5 POET, LLC Latest Developments
11.2 Meihua Group
11.2.1 Meihua Group Company Information
11.2.2 Meihua Group Biomanufacturing in Platform Molecule Product Offered
11.2.3 Meihua Group Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Meihua Group Main Business Overview
11.2.5 Meihua Group Latest Developments
11.3 Fufeng Group
11.3.1 Fufeng Group Company Information
11.3.2 Fufeng Group Biomanufacturing in Platform Molecule Product Offered
11.3.3 Fufeng Group Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Fufeng Group Main Business Overview
11.3.5 Fufeng Group Latest Developments
11.4 CJ Bio
11.4.1 CJ Bio Company Information
11.4.2 CJ Bio Biomanufacturing in Platform Molecule Product Offered
11.4.3 CJ Bio Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 CJ Bio Main Business Overview
11.4.5 CJ Bio Latest Developments
11.5 Eppen Biotech
11.5.1 Eppen Biotech Company Information
11.5.2 Eppen Biotech Biomanufacturing in Platform Molecule Product Offered
11.5.3 Eppen Biotech Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Eppen Biotech Main Business Overview
11.5.5 Eppen Biotech Latest Developments
11.6 Ajinomoto
11.6.1 Ajinomoto Company Information
11.6.2 Ajinomoto Biomanufacturing in Platform Molecule Product Offered
11.6.3 Ajinomoto Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Ajinomoto Main Business Overview
11.6.5 Ajinomoto Latest Developments
11.7 ADM
11.7.1 ADM Company Information
11.7.2 ADM Biomanufacturing in Platform Molecule Product Offered
11.7.3 ADM Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 ADM Main Business Overview
11.7.5 ADM Latest Developments
11.8 Gevo Inc
11.8.1 Gevo Inc Company Information
11.8.2 Gevo Inc Biomanufacturing in Platform Molecule Product Offered
11.8.3 Gevo Inc Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Gevo Inc Main Business Overview
11.8.5 Gevo Inc Latest Developments
11.9 Valero
11.9.1 Valero Company Information
11.9.2 Valero Biomanufacturing in Platform Molecule Product Offered
11.9.3 Valero Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Valero Main Business Overview
11.9.5 Valero Latest Developments
11.10 COFCO TEC
11.10.1 COFCO TEC Company Information
11.10.2 COFCO TEC Biomanufacturing in Platform Molecule Product Offered
11.10.3 COFCO TEC Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 COFCO TEC Main Business Overview
11.10.5 COFCO TEC Latest Developments
11.11 Evonik
11.11.1 Evonik Company Information
11.11.2 Evonik Biomanufacturing in Platform Molecule Product Offered
11.11.3 Evonik Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Evonik Main Business Overview
11.11.5 Evonik Latest Developments
11.12 Ensign Industry
11.12.1 Ensign Industry Company Information
11.12.2 Ensign Industry Biomanufacturing in Platform Molecule Product Offered
11.12.3 Ensign Industry Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Ensign Industry Main Business Overview
11.12.5 Ensign Industry Latest Developments
11.13 Cargill
11.13.1 Cargill Company Information
11.13.2 Cargill Biomanufacturing in Platform Molecule Product Offered
11.13.3 Cargill Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Cargill Main Business Overview
11.13.5 Cargill Latest Developments
11.14 Cathay Biotech
11.14.1 Cathay Biotech Company Information
11.14.2 Cathay Biotech Biomanufacturing in Platform Molecule Product Offered
11.14.3 Cathay Biotech Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Cathay Biotech Main Business Overview
11.14.5 Cathay Biotech Latest Developments
11.15 Corbion
11.15.1 Corbion Company Information
11.15.2 Corbion Biomanufacturing in Platform Molecule Product Offered
11.15.3 Corbion Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Corbion Main Business Overview
11.15.5 Corbion Latest Developments
11.16 China BBCA Group
11.16.1 China BBCA Group Company Information
11.16.2 China BBCA Group Biomanufacturing in Platform Molecule Product Offered
11.16.3 China BBCA Group Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 China BBCA Group Main Business Overview
11.16.5 China BBCA Group Latest Developments
11.17 Jungbunzlauer
11.17.1 Jungbunzlauer Company Information
11.17.2 Jungbunzlauer Biomanufacturing in Platform Molecule Product Offered
11.17.3 Jungbunzlauer Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Jungbunzlauer Main Business Overview
11.17.5 Jungbunzlauer Latest Developments
11.18 RZBC Group
11.18.1 RZBC Group Company Information
11.18.2 RZBC Group Biomanufacturing in Platform Molecule Product Offered
11.18.3 RZBC Group Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 RZBC Group Main Business Overview
11.18.5 RZBC Group Latest Developments
11.19 Primient Covation LLC
11.19.1 Primient Covation LLC Company Information
11.19.2 Primient Covation LLC Biomanufacturing in Platform Molecule Product Offered
11.19.3 Primient Covation LLC Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Primient Covation LLC Main Business Overview
11.19.5 Primient Covation LLC Latest Developments
11.20 Anhui Huaheng Biotechnology
11.20.1 Anhui Huaheng Biotechnology Company Information
11.20.2 Anhui Huaheng Biotechnology Biomanufacturing in Platform Molecule Product Offered
11.20.3 Anhui Huaheng Biotechnology Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Anhui Huaheng Biotechnology Main Business Overview
11.20.5 Anhui Huaheng Biotechnology Latest Developments
11.21 TTCA Co
11.21.1 TTCA Co Company Information
11.21.2 TTCA Co Biomanufacturing in Platform Molecule Product Offered
11.21.3 TTCA Co Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 TTCA Co Main Business Overview
11.21.5 TTCA Co Latest Developments
11.22 Henan Jindan Lactic Acid Technology
11.22.1 Henan Jindan Lactic Acid Technology Company Information
11.22.2 Henan Jindan Lactic Acid Technology Biomanufacturing in Platform Molecule Product Offered
11.22.3 Henan Jindan Lactic Acid Technology Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Henan Jindan Lactic Acid Technology Main Business Overview
11.22.5 Henan Jindan Lactic Acid Technology Latest Developments
11.23 Versalis S.p.A
11.23.1 Versalis S.p.A Company Information
11.23.2 Versalis S.p.A Biomanufacturing in Platform Molecule Product Offered
11.23.3 Versalis S.p.A Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Versalis S.p.A Main Business Overview
11.23.5 Versalis S.p.A Latest Developments
11.24 Jiangsu Guoxin Union Energy
11.24.1 Jiangsu Guoxin Union Energy Company Information
11.24.2 Jiangsu Guoxin Union Energy Biomanufacturing in Platform Molecule Product Offered
11.24.3 Jiangsu Guoxin Union Energy Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Jiangsu Guoxin Union Energy Main Business Overview
11.24.5 Jiangsu Guoxin Union Energy Latest Developments
11.25 Citrique Belge
11.25.1 Citrique Belge Company Information
11.25.2 Citrique Belge Biomanufacturing in Platform Molecule Product Offered
11.25.3 Citrique Belge Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Citrique Belge Main Business Overview
11.25.5 Citrique Belge Latest Developments
11.26 Shandong Kaison Biochemical
11.26.1 Shandong Kaison Biochemical Company Information
11.26.2 Shandong Kaison Biochemical Biomanufacturing in Platform Molecule Product Offered
11.26.3 Shandong Kaison Biochemical Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Shandong Kaison Biochemical Main Business Overview
11.26.5 Shandong Kaison Biochemical Latest Developments
11.27 BioUrja Group
11.27.1 BioUrja Group Company Information
11.27.2 BioUrja Group Biomanufacturing in Platform Molecule Product Offered
11.27.3 BioUrja Group Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 BioUrja Group Main Business Overview
11.27.5 BioUrja Group Latest Developments
11.28 Laiwu Taihe Biochemistry
11.28.1 Laiwu Taihe Biochemistry Company Information
11.28.2 Laiwu Taihe Biochemistry Biomanufacturing in Platform Molecule Product Offered
11.28.3 Laiwu Taihe Biochemistry Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Laiwu Taihe Biochemistry Main Business Overview
11.28.5 Laiwu Taihe Biochemistry Latest Developments
11.29 Roquette Frères
11.29.1 Roquette Frères Company Information
11.29.2 Roquette Frères Biomanufacturing in Platform Molecule Product Offered
11.29.3 Roquette Frères Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 Roquette Frères Main Business Overview
11.29.5 Roquette Frères Latest Developments
11.30 Galactic
11.30.1 Galactic Company Information
11.30.2 Galactic Biomanufacturing in Platform Molecule Product Offered
11.30.3 Galactic Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Galactic Main Business Overview
11.30.5 Galactic Latest Developments
11.31 Henan Xinghan Biotechnology
11.31.1 Henan Xinghan Biotechnology Company Information
11.31.2 Henan Xinghan Biotechnology Biomanufacturing in Platform Molecule Product Offered
11.31.3 Henan Xinghan Biotechnology Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Henan Xinghan Biotechnology Main Business Overview
11.31.5 Henan Xinghan Biotechnology Latest Developments
11.32 Shandong Landian Biological
11.32.1 Shandong Landian Biological Company Information
11.32.2 Shandong Landian Biological Biomanufacturing in Platform Molecule Product Offered
11.32.3 Shandong Landian Biological Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 Shandong Landian Biological Main Business Overview
11.32.5 Shandong Landian Biological Latest Developments
11.33 Godavari Biorefineries
11.33.1 Godavari Biorefineries Company Information
11.33.2 Godavari Biorefineries Biomanufacturing in Platform Molecule Product Offered
11.33.3 Godavari Biorefineries Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 Godavari Biorefineries Main Business Overview
11.33.5 Godavari Biorefineries Latest Developments
11.34 Guangdong Tsingda Smart Biotech
11.34.1 Guangdong Tsingda Smart Biotech Company Information
11.34.2 Guangdong Tsingda Smart Biotech Biomanufacturing in Platform Molecule Product Offered
11.34.3 Guangdong Tsingda Smart Biotech Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 Guangdong Tsingda Smart Biotech Main Business Overview
11.34.5 Guangdong Tsingda Smart Biotech Latest Developments
11.35 Zhejiang Guoguang Biochemistry
11.35.1 Zhejiang Guoguang Biochemistry Company Information
11.35.2 Zhejiang Guoguang Biochemistry Biomanufacturing in Platform Molecule Product Offered
11.35.3 Zhejiang Guoguang Biochemistry Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Zhejiang Guoguang Biochemistry Main Business Overview
11.35.5 Zhejiang Guoguang Biochemistry Latest Developments
11.36 Musashino Chemical
11.36.1 Musashino Chemical Company Information
11.36.2 Musashino Chemical Biomanufacturing in Platform Molecule Product Offered
11.36.3 Musashino Chemical Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 Musashino Chemical Main Business Overview
11.36.5 Musashino Chemical Latest Developments
11.37 Qingdao Langyatai Group
11.37.1 Qingdao Langyatai Group Company Information
11.37.2 Qingdao Langyatai Group Biomanufacturing in Platform Molecule Product Offered
11.37.3 Qingdao Langyatai Group Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 Qingdao Langyatai Group Main Business Overview
11.37.5 Qingdao Langyatai Group Latest Developments
11.38 NATURAL Biological Group
11.38.1 NATURAL Biological Group Company Information
11.38.2 NATURAL Biological Group Biomanufacturing in Platform Molecule Product Offered
11.38.3 NATURAL Biological Group Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 NATURAL Biological Group Main Business Overview
11.38.5 NATURAL Biological Group Latest Developments
11.39 Toray
11.39.1 Toray Company Information
11.39.2 Toray Biomanufacturing in Platform Molecule Product Offered
11.39.3 Toray Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.39.4 Toray Main Business Overview
11.39.5 Toray Latest Developments
11.40 Anhui Xingzhou Pharmaceutical
11.40.1 Anhui Xingzhou Pharmaceutical Company Information
11.40.2 Anhui Xingzhou Pharmaceutical Biomanufacturing in Platform Molecule Product Offered
11.40.3 Anhui Xingzhou Pharmaceutical Biomanufacturing in Platform Molecule Revenue, Gross Margin and Market Share (2021-2026)
11.40.4 Anhui Xingzhou Pharmaceutical Main Business Overview
11.40.5 Anhui Xingzhou Pharmaceutical Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Biomanufacturing in Platform Molecule Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biomanufacturing in Platform Molecule Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of C2 Platform Molecule
Table 4. Major Players of C3 Platform Molecule
Table 5. Major Players of C4 Platform Molecule
Table 6. Major Players of C5 Platform Molecule
Table 7. Major Players of C6 Platform Molecule
Table 8. Major Players of Others
Table 9. Biomanufacturing in Platform Molecule Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Biomanufacturing in Platform Molecule Market Size by Type (2021-2026) & ($ millions)
Table 11. Global Biomanufacturing in Platform Molecule Market Size Market Share by Type (2021-2026)
Table 12. Major Players of Bio-fermentation
Table 13. Major Players of Enzymatic Reaction
Table 14. Biomanufacturing in Platform Molecule Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 15. Global Biomanufacturing in Platform Molecule Market Size by Technology (2021-2026) & ($ millions)
Table 16. Global Biomanufacturing in Platform Molecule Market Size Market Share by Technology (2021-2026)
Table 17. Biomanufacturing in Platform Molecule Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Biomanufacturing in Platform Molecule Market Size by Application (2021-2026) & ($ millions)
Table 19. Global Biomanufacturing in Platform Molecule Market Size Market Share by Application (2021-2026)
Table 20. Global Biomanufacturing in Platform Molecule Revenue by Player (2021-2026) & ($ millions)
Table 21. Global Biomanufacturing in Platform Molecule Revenue Market Share by Player (2021-2026)
Table 22. Biomanufacturing in Platform Molecule Key Players Head office and Products Offered
Table 23. Biomanufacturing in Platform Molecule Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Biomanufacturing in Platform Molecule Market Size by Region (2021-2026) & ($ millions)
Table 27. Global Biomanufacturing in Platform Molecule Market Size Market Share by Region (2021-2026)
Table 28. Global Biomanufacturing in Platform Molecule Revenue by Country/Region (2021-2026) & ($ millions)
Table 29. Global Biomanufacturing in Platform Molecule Revenue Market Share by Country/Region (2021-2026)
Table 30. Americas Biomanufacturing in Platform Molecule Market Size by Country (2021-2026) & ($ millions)
Table 31. Americas Biomanufacturing in Platform Molecule Market Size Market Share by Country (2021-2026)
Table 32. Americas Biomanufacturing in Platform Molecule Market Size by Type (2021-2026) & ($ millions)
Table 33. Americas Biomanufacturing in Platform Molecule Market Size Market Share by Type (2021-2026)
Table 34. Americas Biomanufacturing in Platform Molecule Market Size by Application (2021-2026) & ($ millions)
Table 35. Americas Biomanufacturing in Platform Molecule Market Size Market Share by Application (2021-2026)
Table 36. APAC Biomanufacturing in Platform Molecule Market Size by Region (2021-2026) & ($ millions)
Table 37. APAC Biomanufacturing in Platform Molecule Market Size Market Share by Region (2021-2026)
Table 38. APAC Biomanufacturing in Platform Molecule Market Size by Type (2021-2026) & ($ millions)
Table 39. APAC Biomanufacturing in Platform Molecule Market Size by Application (2021-2026) & ($ millions)
Table 40. Europe Biomanufacturing in Platform Molecule Market Size by Country (2021-2026) & ($ millions)
Table 41. Europe Biomanufacturing in Platform Molecule Market Size Market Share by Country (2021-2026)
Table 42. Europe Biomanufacturing in Platform Molecule Market Size by Type (2021-2026) & ($ millions)
Table 43. Europe Biomanufacturing in Platform Molecule Market Size by Application (2021-2026) & ($ millions)
Table 44. Middle East & Africa Biomanufacturing in Platform Molecule Market Size by Region (2021-2026) & ($ millions)
Table 45. Middle East & Africa Biomanufacturing in Platform Molecule Market Size by Type (2021-2026) & ($ millions)
Table 46. Middle East & Africa Biomanufacturing in Platform Molecule Market Size by Application (2021-2026) & ($ millions)
Table 47. Key Market Drivers & Growth Opportunities of Biomanufacturing in Platform Molecule
Table 48. Key Market Challenges & Risks of Biomanufacturing in Platform Molecule
Table 49. Key Industry Trends of Biomanufacturing in Platform Molecule
Table 50. Global Biomanufacturing in Platform Molecule Market Size Forecast by Region (2027-2032) & ($ millions)
Table 51. Global Biomanufacturing in Platform Molecule Market Size Market Share Forecast by Region (2027-2032)
Table 52. Global Biomanufacturing in Platform Molecule Market Size Forecast by Type (2027-2032) & ($ millions)
Table 53. Global Biomanufacturing in Platform Molecule Market Size Forecast by Application (2027-2032) & ($ millions)
Table 54. POET, LLC Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 55. POET, LLC Biomanufacturing in Platform Molecule Product Offered
Table 56. POET, LLC Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 57. POET, LLC Main Business
Table 58. POET, LLC Latest Developments
Table 59. Meihua Group Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 60. Meihua Group Biomanufacturing in Platform Molecule Product Offered
Table 61. Meihua Group Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Meihua Group Main Business
Table 63. Meihua Group Latest Developments
Table 64. Fufeng Group Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 65. Fufeng Group Biomanufacturing in Platform Molecule Product Offered
Table 66. Fufeng Group Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Fufeng Group Main Business
Table 68. Fufeng Group Latest Developments
Table 69. CJ Bio Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 70. CJ Bio Biomanufacturing in Platform Molecule Product Offered
Table 71. CJ Bio Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. CJ Bio Main Business
Table 73. CJ Bio Latest Developments
Table 74. Eppen Biotech Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 75. Eppen Biotech Biomanufacturing in Platform Molecule Product Offered
Table 76. Eppen Biotech Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Eppen Biotech Main Business
Table 78. Eppen Biotech Latest Developments
Table 79. Ajinomoto Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 80. Ajinomoto Biomanufacturing in Platform Molecule Product Offered
Table 81. Ajinomoto Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Ajinomoto Main Business
Table 83. Ajinomoto Latest Developments
Table 84. ADM Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 85. ADM Biomanufacturing in Platform Molecule Product Offered
Table 86. ADM Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. ADM Main Business
Table 88. ADM Latest Developments
Table 89. Gevo Inc Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 90. Gevo Inc Biomanufacturing in Platform Molecule Product Offered
Table 91. Gevo Inc Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Gevo Inc Main Business
Table 93. Gevo Inc Latest Developments
Table 94. Valero Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 95. Valero Biomanufacturing in Platform Molecule Product Offered
Table 96. Valero Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Valero Main Business
Table 98. Valero Latest Developments
Table 99. COFCO TEC Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 100. COFCO TEC Biomanufacturing in Platform Molecule Product Offered
Table 101. COFCO TEC Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. COFCO TEC Main Business
Table 103. COFCO TEC Latest Developments
Table 104. Evonik Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 105. Evonik Biomanufacturing in Platform Molecule Product Offered
Table 106. Evonik Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Evonik Main Business
Table 108. Evonik Latest Developments
Table 109. Ensign Industry Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 110. Ensign Industry Biomanufacturing in Platform Molecule Product Offered
Table 111. Ensign Industry Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Ensign Industry Main Business
Table 113. Ensign Industry Latest Developments
Table 114. Cargill Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 115. Cargill Biomanufacturing in Platform Molecule Product Offered
Table 116. Cargill Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Cargill Main Business
Table 118. Cargill Latest Developments
Table 119. Cathay Biotech Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 120. Cathay Biotech Biomanufacturing in Platform Molecule Product Offered
Table 121. Cathay Biotech Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Cathay Biotech Main Business
Table 123. Cathay Biotech Latest Developments
Table 124. Corbion Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 125. Corbion Biomanufacturing in Platform Molecule Product Offered
Table 126. Corbion Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Corbion Main Business
Table 128. Corbion Latest Developments
Table 129. China BBCA Group Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 130. China BBCA Group Biomanufacturing in Platform Molecule Product Offered
Table 131. China BBCA Group Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. China BBCA Group Main Business
Table 133. China BBCA Group Latest Developments
Table 134. Jungbunzlauer Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 135. Jungbunzlauer Biomanufacturing in Platform Molecule Product Offered
Table 136. Jungbunzlauer Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Jungbunzlauer Main Business
Table 138. Jungbunzlauer Latest Developments
Table 139. RZBC Group Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 140. RZBC Group Biomanufacturing in Platform Molecule Product Offered
Table 141. RZBC Group Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. RZBC Group Main Business
Table 143. RZBC Group Latest Developments
Table 144. Primient Covation LLC Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 145. Primient Covation LLC Biomanufacturing in Platform Molecule Product Offered
Table 146. Primient Covation LLC Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Primient Covation LLC Main Business
Table 148. Primient Covation LLC Latest Developments
Table 149. Anhui Huaheng Biotechnology Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 150. Anhui Huaheng Biotechnology Biomanufacturing in Platform Molecule Product Offered
Table 151. Anhui Huaheng Biotechnology Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Anhui Huaheng Biotechnology Main Business
Table 153. Anhui Huaheng Biotechnology Latest Developments
Table 154. TTCA Co Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 155. TTCA Co Biomanufacturing in Platform Molecule Product Offered
Table 156. TTCA Co Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. TTCA Co Main Business
Table 158. TTCA Co Latest Developments
Table 159. Henan Jindan Lactic Acid Technology Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 160. Henan Jindan Lactic Acid Technology Biomanufacturing in Platform Molecule Product Offered
Table 161. Henan Jindan Lactic Acid Technology Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. Henan Jindan Lactic Acid Technology Main Business
Table 163. Henan Jindan Lactic Acid Technology Latest Developments
Table 164. Versalis S.p.A Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 165. Versalis S.p.A Biomanufacturing in Platform Molecule Product Offered
Table 166. Versalis S.p.A Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 167. Versalis S.p.A Main Business
Table 168. Versalis S.p.A Latest Developments
Table 169. Jiangsu Guoxin Union Energy Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 170. Jiangsu Guoxin Union Energy Biomanufacturing in Platform Molecule Product Offered
Table 171. Jiangsu Guoxin Union Energy Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 172. Jiangsu Guoxin Union Energy Main Business
Table 173. Jiangsu Guoxin Union Energy Latest Developments
Table 174. Citrique Belge Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 175. Citrique Belge Biomanufacturing in Platform Molecule Product Offered
Table 176. Citrique Belge Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 177. Citrique Belge Main Business
Table 178. Citrique Belge Latest Developments
Table 179. Shandong Kaison Biochemical Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 180. Shandong Kaison Biochemical Biomanufacturing in Platform Molecule Product Offered
Table 181. Shandong Kaison Biochemical Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 182. Shandong Kaison Biochemical Main Business
Table 183. Shandong Kaison Biochemical Latest Developments
Table 184. BioUrja Group Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 185. BioUrja Group Biomanufacturing in Platform Molecule Product Offered
Table 186. BioUrja Group Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 187. BioUrja Group Main Business
Table 188. BioUrja Group Latest Developments
Table 189. Laiwu Taihe Biochemistry Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 190. Laiwu Taihe Biochemistry Biomanufacturing in Platform Molecule Product Offered
Table 191. Laiwu Taihe Biochemistry Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 192. Laiwu Taihe Biochemistry Main Business
Table 193. Laiwu Taihe Biochemistry Latest Developments
Table 194. Roquette Frères Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 195. Roquette Frères Biomanufacturing in Platform Molecule Product Offered
Table 196. Roquette Frères Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 197. Roquette Frères Main Business
Table 198. Roquette Frères Latest Developments
Table 199. Galactic Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 200. Galactic Biomanufacturing in Platform Molecule Product Offered
Table 201. Galactic Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 202. Galactic Main Business
Table 203. Galactic Latest Developments
Table 204. Henan Xinghan Biotechnology Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 205. Henan Xinghan Biotechnology Biomanufacturing in Platform Molecule Product Offered
Table 206. Henan Xinghan Biotechnology Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 207. Henan Xinghan Biotechnology Main Business
Table 208. Henan Xinghan Biotechnology Latest Developments
Table 209. Shandong Landian Biological Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 210. Shandong Landian Biological Biomanufacturing in Platform Molecule Product Offered
Table 211. Shandong Landian Biological Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 212. Shandong Landian Biological Main Business
Table 213. Shandong Landian Biological Latest Developments
Table 214. Godavari Biorefineries Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 215. Godavari Biorefineries Biomanufacturing in Platform Molecule Product Offered
Table 216. Godavari Biorefineries Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 217. Godavari Biorefineries Main Business
Table 218. Godavari Biorefineries Latest Developments
Table 219. Guangdong Tsingda Smart Biotech Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 220. Guangdong Tsingda Smart Biotech Biomanufacturing in Platform Molecule Product Offered
Table 221. Guangdong Tsingda Smart Biotech Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 222. Guangdong Tsingda Smart Biotech Main Business
Table 223. Guangdong Tsingda Smart Biotech Latest Developments
Table 224. Zhejiang Guoguang Biochemistry Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 225. Zhejiang Guoguang Biochemistry Biomanufacturing in Platform Molecule Product Offered
Table 226. Zhejiang Guoguang Biochemistry Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 227. Zhejiang Guoguang Biochemistry Main Business
Table 228. Zhejiang Guoguang Biochemistry Latest Developments
Table 229. Musashino Chemical Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 230. Musashino Chemical Biomanufacturing in Platform Molecule Product Offered
Table 231. Musashino Chemical Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 232. Musashino Chemical Main Business
Table 233. Musashino Chemical Latest Developments
Table 234. Qingdao Langyatai Group Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 235. Qingdao Langyatai Group Biomanufacturing in Platform Molecule Product Offered
Table 236. Qingdao Langyatai Group Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 237. Qingdao Langyatai Group Main Business
Table 238. Qingdao Langyatai Group Latest Developments
Table 239. NATURAL Biological Group Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 240. NATURAL Biological Group Biomanufacturing in Platform Molecule Product Offered
Table 241. NATURAL Biological Group Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 242. NATURAL Biological Group Main Business
Table 243. NATURAL Biological Group Latest Developments
Table 244. Toray Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 245. Toray Biomanufacturing in Platform Molecule Product Offered
Table 246. Toray Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 247. Toray Main Business
Table 248. Toray Latest Developments
Table 249. Anhui Xingzhou Pharmaceutical Details, Company Type, Biomanufacturing in Platform Molecule Area Served and Its Competitors
Table 250. Anhui Xingzhou Pharmaceutical Biomanufacturing in Platform Molecule Product Offered
Table 251. Anhui Xingzhou Pharmaceutical Biomanufacturing in Platform Molecule Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 252. Anhui Xingzhou Pharmaceutical Main Business
Table 253. Anhui Xingzhou Pharmaceutical Latest Developments


List of Figures
Figure 1. Biomanufacturing in Platform Molecule Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biomanufacturing in Platform Molecule Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biomanufacturing in Platform Molecule Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biomanufacturing in Platform Molecule Sales Market Share by Country/Region (2025)
Figure 8. Biomanufacturing in Platform Molecule Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biomanufacturing in Platform Molecule Market Size Market Share by Type in 2025
Figure 10. Global Biomanufacturing in Platform Molecule Market Size Market Share by Technology in 2025
Figure 11. Biomanufacturing in Platform Molecule in Energy
Figure 12. Global Biomanufacturing in Platform Molecule Market: Energy (2021-2026) & ($ millions)
Figure 13. Biomanufacturing in Platform Molecule in Agriculture
Figure 14. Global Biomanufacturing in Platform Molecule Market: Agriculture (2021-2026) & ($ millions)
Figure 15. Biomanufacturing in Platform Molecule in Food and Beverages
Figure 16. Global Biomanufacturing in Platform Molecule Market: Food and Beverages (2021-2026) & ($ millions)
Figure 17. Biomanufacturing in Platform Molecule in Consumer Goods and Daily Chemicals
Figure 18. Global Biomanufacturing in Platform Molecule Market: Consumer Goods and Daily Chemicals (2021-2026) & ($ millions)
Figure 19. Biomanufacturing in Platform Molecule in Pharmaceuticals
Figure 20. Global Biomanufacturing in Platform Molecule Market: Pharmaceuticals (2021-2026) & ($ millions)
Figure 21. Biomanufacturing in Platform Molecule in Others
Figure 22. Global Biomanufacturing in Platform Molecule Market: Others (2021-2026) & ($ millions)
Figure 23. Global Biomanufacturing in Platform Molecule Market Size Market Share by Application in 2025
Figure 24. Global Biomanufacturing in Platform Molecule Revenue Market Share by Player in 2025
Figure 25. Global Biomanufacturing in Platform Molecule Market Size Market Share by Region (2021-2026)
Figure 26. Americas Biomanufacturing in Platform Molecule Market Size 2021-2026 ($ millions)
Figure 27. APAC Biomanufacturing in Platform Molecule Market Size 2021-2026 ($ millions)
Figure 28. Europe Biomanufacturing in Platform Molecule Market Size 2021-2026 ($ millions)
Figure 29. Middle East & Africa Biomanufacturing in Platform Molecule Market Size 2021-2026 ($ millions)
Figure 30. Americas Biomanufacturing in Platform Molecule Value Market Share by Country in 2025
Figure 31. United States Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 32. Canada Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 33. Mexico Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 34. Brazil Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 35. APAC Biomanufacturing in Platform Molecule Market Size Market Share by Region in 2025
Figure 36. APAC Biomanufacturing in Platform Molecule Market Size Market Share by Type (2021-2026)
Figure 37. APAC Biomanufacturing in Platform Molecule Market Size Market Share by Application (2021-2026)
Figure 38. China Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 39. Japan Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 40. South Korea Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 41. Southeast Asia Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 42. India Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 43. Australia Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 44. Europe Biomanufacturing in Platform Molecule Market Size Market Share by Country in 2025
Figure 45. Europe Biomanufacturing in Platform Molecule Market Size Market Share by Type (2021-2026)
Figure 46. Europe Biomanufacturing in Platform Molecule Market Size Market Share by Application (2021-2026)
Figure 47. Germany Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 48. France Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 49. UK Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 50. Italy Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 51. Russia Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 52. Middle East & Africa Biomanufacturing in Platform Molecule Market Size Market Share by Region (2021-2026)
Figure 53. Middle East & Africa Biomanufacturing in Platform Molecule Market Size Market Share by Type (2021-2026)
Figure 54. Middle East & Africa Biomanufacturing in Platform Molecule Market Size Market Share by Application (2021-2026)
Figure 55. Egypt Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 56. South Africa Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 57. Israel Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 58. Turkey Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 59. GCC Countries Biomanufacturing in Platform Molecule Market Size Growth 2021-2026 ($ millions)
Figure 60. Americas Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 61. APAC Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 62. Europe Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 63. Middle East & Africa Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 64. United States Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 65. Canada Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 66. Mexico Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 67. Brazil Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 68. China Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 69. Japan Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 70. Korea Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 71. Southeast Asia Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 72. India Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 73. Australia Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 74. Germany Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 75. France Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 76. UK Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 77. Italy Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 78. Russia Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 79. Egypt Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 80. South Africa Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 81. Israel Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 82. Turkey Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)
Figure 83. Global Biomanufacturing in Platform Molecule Market Size Market Share Forecast by Type (2027-2032)
Figure 84. Global Biomanufacturing in Platform Molecule Market Size Market Share Forecast by Application (2027-2032)
Figure 85. GCC Countries Biomanufacturing in Platform Molecule Market Size 2027-2032 ($ millions)